Drugs /

samarium sm-153

Back to Drugs List

Overview

NCI Definition [1]:
A radioactive substance used in the treatment of bone cancer and bone metastases (cancers that have spread from the original tumor to the bone). Samarium 153 is a radioactive form of the element samarium. It collects in bone, where it releases radiation that may kill cancer cells. It is a type of radioisotope.

Clinical Trials

View Clinical Trials for samarium sm-153

Samarium sm-153 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating samarium sm-153, 1 is phase 2 (1 open).

Prostate carcinoma is the most common disease being investigated in samarium sm-153 clinical trials [2].

Drug Details

Synonyms [2]:
samarium 153, samarium 153, 153sm, samarium, isotope of mass 153, sm-153, samarium 153 (substance), samarium sm153, samarium sm-153
NCIT ID [1]:
C1809
SNOMED ID [1]:
C-B1134

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.